RANCHO SANTA MARGARITA, Calif. - eTradeWire -- MedWand Solutions, Inc., the ultimate healthcare solution and a pioneer in telehealth technology, is pleased to announce its recent regulatory clearance in Thailand. This latest approval allows MedWand to empower a broader spectrum of clinicians and healthcare providers, enabling them to elevate care standards and grant easier access to healthcare services.

"The regulatory clearance in Thailand reflects our dedication to making comprehensive remote healthcare services accessible worldwide," shared MedWand Senior Director of International Business Development, Stuart English. "We are thrilled to bring MedWand to Thailand, addressing healthcare needs and creating new opportunities for collaboration with international partners."

More on eTradeWire News

• MetaDroom Sets to Become Potential Crypto in 2025
• GBAMFS Condemns Restrictive Publisher Policies Threatening Gamer Free Expression
• Upcoming Book "Democratizing Violence: The Rise of Open-Source Warfare and the Decline of State Control" Available for Pre-Order Now
• Real Recovery Podcast: Amplifying Voices in the Recovery Movement
• SUN & STARS INT'L FILM FESTIVAL Announces Closing Night Film & Attending VIPs

MedWand is the ultimate healthcare solution, seamlessly integrating traditional tools and Bluetooth connectivity for vitals capture and remote patient evaluations to enhance efficiency, convenience, and access to care. Following its FDA clearance and product launch in the United States in 2022, MedWand has gained significant traction with major US health systems, telehealth companies, large private practices, and employers.

"Following thorough research, we have identified the MedWand multi-sensor vitals capture device, together with the VirtualCare telemedicine platform, as the pivotal components essential for revolutionizing telemedicine services. This combination is poised to facilitate advanced clinical care accessible to patients regardless of their location, eliminating the necessity for hospital visits," commented Dr. Supornchai Kongpatanakul, President of Kitmeechai Trading Co., Ltd.

The device's versatility and ease of use make it a valuable asset for both healthcare professionals and patients. Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, and pulse rate, heart, lung and abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. Through approved 3rd party Bluetooth peripherals, MedWand can also seamlessly capture blood pressure, glucometer, spirometry, and weight data.

More on eTradeWire News

• CULTURE & COCKTAILS Welcomed 100+ to Conversation with Comedy Writer Alan Zweibel
• FLOW FX Announces Development of Omega (Ω): The Autonomous AI Agent Revolutionizing Investments
• The Band Contemporary to Release Sophomore Album Revolution on January 20, 2025
• Much anticipated last book in the Song of Echoes epic fantasy series is published
• Boys & Girls Clubs of Silicon Valley names Veronica Jowers Chief of Staff

For more information on MedWand visit www.medwand.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at https://www.medwandhealth.com/contact.

*Electrocardiogram feature is currently awaiting US FDA 510(k) clearance.